Pharmacological and non-pharmacological recanalization strategies in acute ischemic stroke

Frontiers in Neurology

Volumn MAY, Issue , 2011, Pages

  Frendl, Anita ^a   Csiba, László ^a  

^a UNIVERSITY OF DEBRECEN   (Hungary)

Author keywords

Acutestroke; Alteplase; Intra arterialthrombolysis; Intravenousthrombolysis; Mechanismofrecanalization; Strokeunit; Therapeutictimewindow; Thrombectomy

Indexed keywords

EID: 80054746986     PISSN: None     EISSN: 16642295     Source Type: Journal    
DOI: 10.3389/fneur.2011.00032     Document Type: Article

References (53)

1. Adams, H. P. Jr., del Zoppo, G., Alberts, M. J., Bhatt, D. L., Brass, L., Furlan, A., Grubb, R. L., Higashida, R. T., Jauch, E. C., Kidwell, C., Lyden, P. D., Morgenstern, L. B., Qureshi, A. I., Rosenwasser, R. H., Scott, P. A., Wijdicks, E. F., and American Heart Association/American Stroke Association Stroke Council, Amer-ican Heart Association/American Stroke Association Clinical Car-diology Council, American Heart Association/American Stroke Asso-ciation Cardiovascular Radiology and Intervention Council, Ather-osclerotic Peripheral Vascular Dis-ease Working Group, Quality of Care Outcomes in Research Inter-disciplinary Working Group. (2007). Guidelines for the early manage-ment of adults with ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council, Clin-ical Cardiology Council, Cardio-vascular Radiology and Interven-tion Council, and the Atheroscle-rotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: the American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists. Circulation 115, e478-e534.
2. Alberts, M. J., Latchaw, R. E., Selman, W. R., Shephard, T., Hadley, M. N., Brass, L. M., Koroshetz, W., Marler, J. R., Booss, J., Zorowitz, R. D., Croft, J. B., Magnis, E., Mulligan, D., Jagoda, A., O'Connor, R., Cawley, C. M., Connors, J. J., Rose-DeRenzy, J. A., Emr, M., Warren, M., and Walker,M. D. (2005). Recommenda-tions for comprehensive stroke cen-ters: a consensus statement from the Brain Attack Coalition. Stroke 36, 1597-1616.
3. Alexandrov, A. V. (2010a). Ultrasound enhanced thrombolysis for stroke. J. Int. Med. 267, 209-219.
4. Alexandrov, A. V. (2010b). Current and future recanalisation strategies for acute ischemic stroke (Review). J. Intern. Med. 267, 209-219.
5. Astrup, J., Siesjö, B. K., and Symon, L. (1981). Thresholds in cerebral ischemia - the ischemic penumbra. Stroke 12, 723-725.
6. Cornu, C., Amsallem, E., and Serradj-Jaillard, A. A. (2001). Throm-bolytic therapy for acute ischemic stroke. Am. J. Cardiovasc. Drugs 4, 281-292.
7. Csiba, L., Paschen, W., and Hoss-mann, K. A. (1983). A topo-graphic quantitative method for measuring brain tissue pH under physiological and pathophysiolog-ical conditions. Brain Res. 289, 334-337.
8. Csiba, L., Paschen, W., and Mies, G. (1985). Regional changes in tissue pH and glucose content during cortical spreading depres-sion in rat brain. Brain Res. 336, 167-170.
9. Danton, G. H., and Dietrich, W. D. (2004). The search for neuroprotec-tive strategies in stroke. AJNR Am. J. Neuroradiol. 25, 181-194.
10. Davis, S. M., Donnan, G. A., Parsons, M. W., Levi, C., Butcher, K. S., Peeters, A., Barber, P. A., Bladin, C., De Silva, D. A., Byrnes, G., Chalk, J. B., Fink, J. N., Kimber, T.E., Schultz, D., Hand, P. J., Frayne, J., Hankey, G., Muir, K., Gerraty, R., Tress, B. M., Desmond, P. M., and EPITHET investigators. (2008). Effects of alteplase beyond3hafter stroke in the echoplanar imaging thrombolytic evaluation trial (EPI-THET): a placebo-controlled ran-domised trial. Lancet Neurol. 7, 299-309.
11. del Zoppo,G. J.,Higashida,R. T.,Furlan, A. J., Pessin, M. S., Rowley, H. A., and Gent, M. (1998). PROACT: a phase II randomized trial of recom-binant pro-urokinase by direct arte-rial delivery in acute middle cere-bral artery stroke. PROACT inves-tigators.Prolyseinacutecere-bral thromboembolism. Stroke 29, 4-11.
12. Flint, A. C., Duckwiler, G. R., Budzik, R. F., Liebeskind, D. S., Smith, W. S., and MERCI and Multi MERCI Writ-ing Committee. (2007). Mechani-cal thrombectomy of intracranial internal carotid occlusion: pooled results of the MERCI and multi MERCI part I trials. Stroke 38, 1274-1280.
13. Furlan, A., Higashida, R., Wechsler, L., Gent, M., Rowley, H., Kase, C., Pessin, M., Ahuja, A., Callahan, F., Clark, W. M., Silver, F., and Rivera, F. (1999). Intra-arterial prouroki-nase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. Prolyse in acute cerebral thromboembolism. JAMA 282, 2003-2011.
14. Furlan, A. J., and Abou-Chebl, A. (2002). The role of recombi-nant pro-urokinase (r-pro-UK) and intra-arterial thrombolysis in acute ischaemic stroke: the PROACT tri-als. Prolyse in acute cerebral throm-boembolism. Curr. Med. Res. Opin. 18(Suppl. 2), s44-s47.
15. Hacke, W., Albers, G., Al-Rawi, Y., Bogousslavsky, J., Davalos, A., Eliasziw, M., Fischer, M., Furlan, A., Kaste, M., Lees, K. R., Soehngen, M., Warach, S., and DIAS Study Group. (2005). The desmoteplase in acute ischemic stroke trial (DIAS): a phase II MRI-based 9-hour window acute stroke thrombolysis trial with intravenous desmoteplase. Stroke 36, 66-73.
16. Haley, E. C. Jr., Lyden, P. D., John-ston, K. C., Hemmen, T. M., and TNK in Stroke Investigators. (2005). A pilot dose-escalation safety study of tenecteplase in acute ischemic stroke. Stroke 36, 607-612.
17. IMS Study Investigators. (2004). Com-bined intravenous and intra-arterial recanalisation for acute ischemic stroke: the Interventional Manage-ment of Stroke Study. Stroke 35, 904-911.
18. IMS II Trial Investigators. (2007). The Interventional Management of Stroke (IMS) II Study. Stroke 38, 2127-2135.
19. Jovin, T. G., Gupta, R., Uchino, K., Jun-greis, C. A., Wechsler, L. R., Ham-mer, M. D., Tayal, A., and Horowitz, M. B. (2005). Emergent stenting of extracranial internal carotid artery occlusion in acute stroke has a high revascularization rate. Stroke 36, 2426-2430.
20. Kakuda, W., Lansberg, M. G., Thijs, V. N., Kemp, S. M., Bammer, R., Wech-sler, L. R., Moseley, M. E., Marks, M. P.,Albers, G. W., and DEFUSE Inves-tigators. (2008). Optimal definition for PWI/DWI mismatch in acute ischemic stroke patients. J. Cereb. Blood Flow Metab. 28, 887-891.
21. Khatri, P., Hill, M. D., Palesch, Y. Y., Spilker, J., Jauch, E. C., Carrozzella, J. A., Demchuk, A. M., Martin, R., Mauldin, P., Dillon, C., Ryckborst, K. J., Janis, S., Tomsick, T. A., Brod-erick, J. P., and Interventional Man-agement of Stroke III Investigators. (2008). Methodology of the Inter-ventional Management of Stroke III Trial. Int. J. Stroke 3, 130-137.
22. Kuroiwa, T., Miyasaka, N., Fengyo, Z., Yamada, I., Nakane, M., Nagaoka, T., Tamura, A., Ohno, K. (2007). Exper-imental ischemic brain edema: mor-phological and magnetic resonance imaging findings. Neurosurg. Focus 22, E11.
23. Kwiatkowski, T. G., Libman, R. B., Frankel, M., Tilley, B. C., Morgen-stern, L. B., Lu, M., Broderick, J. P., Lewandowski, C. A., Marler, J. R., Levine, S. R., and Brott, T. (1999). Effects of tissue plasminogen activa-tor for acute ischemic stroke at one year. National Institute of Neurolog-ical Disorders and Stroke Recombi-nant Tissue Plasminogen Activator Stroke Study Group. N.Engl.J.Med. 340, 1781-1787.
24. Levy, E. I., Siddiqui, A. H., Crumlish, A., Snyder, K. V., Hauck, E. F., Fiorella, D. J., Hopkins, L. N., and Mocco, J. (2009). First Food and Drug Administration-approved prospec-tive trial of primary intracra-nial stenting for acute stroke: SARIS (stent-assisted recanalization in acute ischemic stroke). Stroke 40, 3552-3556.
25. Lewandowski, C. A., Frankel, M., Tom-sick, T. A., Broderick, J., Frey, J., Clark, W., Starkman, S., Grotta, J., Spilker, J., Khoury, J., and Brott, T. (1999). Combined intravenous and intra-arterial r-TPA versus intra-arterial therapy of acute ischemic stroke: emergency management of stroke (EMS) bridging trial. Stroke 30, 2598-2605.
26. Liebeskind, D. S. (2009). Reversing stroke in the 2010s: lessons from desmoteplase in acute ischemic stroke-2 (DIAS-2). Stroke 40, 3156-3158.
27. Marler, J. R., Tilley, B. C., and Lu, M., Brott, T. G., Lyden, P. C., Grotta, J. C., Broderick, J. P., Levine, S. R., Frankel, M. P., Horowitz, S. H., Haley, E. C. Jr., Lewandowski, C. A., and Kwiatkowski, T. P. (2000). Early stroke treatment associated with better outcome: the NINDS rt-PA stroke study. Neurology 55, 1649-1655.
28. Micieli, G., Marcheselli, S., and Tosi, P. (2009). Safety and efficacy of alteplase in the treatment of acute ischemic stroke. Vasc. Health Risk Manag. 5, 397-409.
29. Molina, C. A., Grotta, J. C., Garami, Z., Ford, S. R., Alvarez-Sabin, J., Montaner, J., Saqqur, M., Dem-chuk, A. M., Moyé, L. A., Hill, M. D., Wojner, A. W., CLOT-BUST Investigators. (2004). Ultrasound-enhanced systemic thrombolysis for acute ischemic stroke. N.Engl.J.Med.351, 2170-2178.
30. Molina, C. A., Ribo, M., Rubiera, M., Montaner, J., Santamarina, E., Delgado-Mederos, R., Arenillas, J. F., Huertas, R., Purroy, F., Delgado, P., and Alvarez-Sabín, J. (2006). Microbubble administration accel-erates clot lysis during continuous 2-MHz ultrasound monitoring in stroke patients treated with intra-venous tissue plasminogen activator. Stroke 37, 425-429.
31. Murray, V., Norrving, B., Sandercock, P. A. G., Terént, A., Wardlaw, J. M., and Wester, P. (2010). The molecular basis of thrombolysis and its clinical application in stroke. J. Intern. Med. 267, 191-208.
32. Nogueira, R. G., Liebeskind, D. S., Sung, G., Duckwiler, G., and Smith, W. S. (2009). MERCI; Multi MERCI Writing Committee. Predictors of good clinical outcomes, mortality, and successful revascularization in patients with acute ischemic stroke undergoing thrombectomy: pooled analysis of the mechanical embo-lus removal in cerebral ischemia (MERCI) and Multi MERCI Trials. Stroke 40, 3777-3783.
33. Ogawa, A., Mori, E., Minematsu, K., Taki, W., Takahashi, A., Nemoto, S., Miyamoto, S., Sasaki, M., Inoue, T., and MELT Japan Study Group. (2007). Randomized trial of intraar-terial infusion of urokinase within 6 hours of middle cerebral artery stroke: the middle cerebral artery embolism local fibrinolytic inter-vention trial (MELT) Japan. Stroke 38, 2633-2639.
34. Olivot, J. M., Mlynash, M., Thijs, V. N., Purushotham, A., Kemp, S., Lans-berg, M. G., Wechsler, L., Gold, G. E., Bammer, R., Marks, M. P., and Albers, G. W. (2009). Geography, structure, and evolution of diffusion and perfusion lesions in diffusion and perfusion imaging evaluation for understanding stroke evolution (DEFUSE). Stroke 40, 3245-3251.
35. Paciaroni, M., Medeiros, E., and Bogousslavsky, J. (2009). Desmoteplase. Expert Opin. Biol. Ther. 9, 773-778.
36. Parsons, M. W., Miteff, F., Bateman, G. A., Spratt, N., Loiselle, A., Attia, J., and Levi, C. R. (2009). Acute ischemic stroke: imaging-guided tenecteplase treatment in an extended time window. Neurology 72, 915-921.
37. Penumbra Pivotal Stroke Trial Inves-tigators. (2009). The penumbra pivotal stroke trial: safety and effectiveness of a new generation of mechanical devices for clot removal in intracranial large vessel occlusive disease. Stroke 40, 2761-2768.
38. Qureshi, A. I., Harris-Lane, P., Kir-mani, J. F., Janjua, N., Divani, A. A., Mohammad, Y. M., Suarez, J. I., and Montgomery, M. O. (2006). Intra-arterial reteplase and intra-venous abciximab in patients with acute ischemic stroke: an open-label, dose-ranging, phase I study. Neu- rosurgery 59, 789-796; discussion 796-797.
39. Qureshi, A. I., Pande, R. U., Kim, S. H., Hanel, R. A., Kirmani, J. F., and Yahia, A. M. (2002). Third gener-ation thrombolytics for the treat-ment of ischemic stroke. Curr. Opin. Investig. Drugs 3, 1729-1732.
40. Saver, J. F. (2006). Time is brain!-quantified. Stroke 37, 263-266.
41. Saver, J. L. (2004). Number needed to treat estimates incorporating effects over the entire range of clinical out-comes: novel derivation method and application to thrombolytic therapy for acute stroke. Arch. Neurol. 61, 1066-1067.
42. Saver, J. L. (2007). Intra-arterial fib-rinolysis for acute ischemic stroke: the message of MELT. Stroke 38, 2627-2628.
43. Saver,J. L.,Gornbein,J.,Grotta,J.,Liebe-skind, D., Lutsep, H., Schwamm, L., Scott, P., and Starkman, S. (2009). Number needed to treat to benefit and to harm for intravenous tissue plasminogen activator therapy in the 3-to 4.5-hour window: joint out-come table analysis of the ECASS 3 trial. Stroke 40, 2433-2437.
44. Saver, J. L., Smith, E. E., Fonarow, G. C., Reeves, M. J., Zhao, X., Olson, D. M., Schwamm, L. H., and on behalf of the GWTG-Stroke Steering Com-mittee. (2010). The "golden hour" and acute brain ischemia: presenting features and lytic therapy in >30,000 patients arriving within 60 minutes of stroke onset stroke. Stroke 41, 1431-1439.
45. Segura, T., Calleja, S., and Jordan, J. (2008). Recommendations and treatment strategies for the man-agement of acute ischemic stroke. Expert Opin. Pharmacother. 9, 1071-1085.
46. Shi, Z. S., Loh, Y., Walker, G., and Duckwiler, G. R. (2010). Clinical outcomes in middle cerebral artery trunk occlusions versus secondary division occlusions after mechani-cal thrombectomy: pooled analysis of the mechanical embolus removal in cerebral ischemia (MERCI) and multi MERCI trials. Stroke 41, 953-960.
47. Smith, W. S., Sung, G., Starkman, S., Saver, J. L., Kidwell, C. S., Gobin, Y. P., Lutsep, H. L., Nesbit, G. M., Grobelny, T., Rymer, M. M., Silver-man, I. E., Higashida, R. T., Budzik, R. F., Marks, M. P., and MERCI Trial Investigators. (2008a). Safety and efficacy of mechanical embolec-tomy in acute stroke: results of the MERCI trial. Stroke 39, 1205-1212.
48. Smith, W. S., Sung, G., Saver, J., Budzik, R., Duckwiler, G., Liebeskind, D. S., Lutsep, H. L., Rymer, M. M., Higashida, R. T., Starkman, S., Gobin,Y. P., Multi MERCI Investiga-tors, Frei, D., Grobelny, T., Hellinger, F.,Huddle,D.,Kidwell,C.,Koroshetz, W., Marks, M., Nesbit, G., and Sil-verman, I. E. (2008b). Mechanical thrombectomy for acute ischemic stroke: final results of the multi MERCI trial. Stroke 39, 1205-1212.
49. The National Institute of Neurolog-ical Disorders and Stroke rt-PA Stroke Study Group. (1995). Tis-sue plasminogen activator for acute ischemic stroke. N.Engl.J.Med.333, 1581-1587.
50. Tomsick, T., Broderick, J., Carrozella, J., Khatri, P., Hill, M., Palesch, Y., Khoury, J., and Interventional Management of Stroke II Investi-gators. (2008). Revascularization results in the Interventional Management of Stroke II trial. AJNR Am. J. Neuroradiol. 29, 582-587.
51. Uflacker, R., Schönholz, C., Papamiti-sakis, N., and SENTIS trial. (2008). Interim report of the SENTIS trial: cerebral perfusion augmentation via partial aortic occlusion in acute ischemic stroke. J. Cardiovasc. Surg. (Torino) 49, 715-721.
52. Wardlaw, J. M., Murray, V., Berge, E., and Del Zoppo, G. J. (2009). Thrombolysis for acute ischaemic stroke. Cochrane Database Syst. Rev. CD000213.
53. Wintermark, M., Albers, G. W., Alexan-drov, A. V., Alger, J. R., Bammer, R., Baron, J. C., Davis, S., Demaer-schalk, B. M., Derdeyn, C. P., Don-nan, G. A., Eastwood, J. D., Fiebach, J. B., Fisher, M., Furie, K. L., Gold-makher, G. V., Hacke, W., Kidwell, C. S., Kloska, S. P., Köhrmann, M., Koroshetz, W., Lee, T. Y., Lees, K. R., Lev, M. H., Liebeskind, D. S., Ostergaard,L.,Powers,W. J.,Proven-zale, J., Schellinger, P., Silbergleit, R., Sorensen, A. G., Wardlaw, J., Wu, O., and Warach, S. (2008). Acute stroke imaging research roadmap. Stroke 39, 1621-1628.